The latest cancer drugs news
Browsing: Cancer Drug News
Get a load of ZIF! Better delivery of cancer immunotherapy
Loading a cancer immunotherapy drug onto a metal organic framework improves both its delivery and…
Immunotherapy — targeted drug combination improves survival in advanced kidney cancer
Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy…
European commission approves tucatinib for locally advanced/metastatic HER2 positive breast cancer
It was announced today that the European Commission (EC) has granted marketing authorisation for tucatinib…
Medication-based starvation of cancer cells
The drug thalidomide was sold as a sedative under the trade name Contergan in the…
FDA grants accelerated approval to umbralisib for marginal zone lymphoma and follicular lymphoma
On February 5, 2021, the Food and Drug Administration granted accelerated approval to umbralisib, a…
Mathematical method developed to predict cancer and drug-specific immunotherapy efficacy
Researchers from Houston Methodist, USA, have developed a mathematical model to predict how specific cancers…
Drug ‘breakthrough’ gives longest-ever survival in non-resectable liver cancer patients
The IMbrave150 trial found median overall survival was 19.2 months in patients treated with atezo…
Drug is promising against pancreatic and breast cancers
ProAgio, a drug developed by Georgia State University (USA) biology professor Zhi-Ren Liu and his…
Popular breast cancer drugs don’t work the way we thought they did
Some of the most commonly used drugs for treating hereditary breast and ovarian cancers may…
Ionic liquid uniformly delivers chemotherapy to tumours while destroying cancerous tissue
A Mayo Clinic team, led by Rahmi Oklu, M.D., Ph.D., a vascular and interventional radiologist…